Below are the financial statements of Galderma Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 |
|---|---|---|
| Net sales | 4,410a | 4,082a |
| Other revenue | 30a | 35a |
| Cost of goods sold | -1,355a | -1,232a |
| Gross profit | 3,085a | 2,885a |
| Research and development | -260a | -287a |
| Sales and marketing | -1,377a | -1,292a |
| General and administrative | -543a | -467a |
| Medical and regulatory | -95a | -95a |
| Distribution | -132a | -133a |
| Other income / (expenses) | -33a | -75a |
| Operating profit | 645a | 536a |
| Financial income | 46a | 38a |
| Financial expenses | -374a | -564a |
| Foreign exchange gain / (loss) on financing activities | -7a | 2a |
| Income before tax | 310a | 11a |
| Income taxes | -79a | -68a |
| Net income / (loss) | 231a | -57a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Galderma Group’s data sources below and access millions more through our Disclosure Search.